Pretreatment Lymphocyte to Monocyte Ratio as a Prognostic Marker for Advanced Pulmonary Squamous Cell Carcinoma Treated With Chemotherapy.

about

Pretreatment Lymphocyte to Monocyte Ratio as a Prognostic Marker for Advanced Pulmonary Squamous Cell Carcinoma Treated With Chemotherapy.

Item

http://www.wikidata.org/entity/Q55518947

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Pretreatment Lymphocyte to Mon ...... oma Treated With Chemotherapy.

@en

Pretreatment Lymphocyte to Mon ...... oma Treated With Chemotherapy.

@nl

type

Item

label

Pretreatment Lymphocyte to Mon ...... oma Treated With Chemotherapy.

@en

Pretreatment Lymphocyte to Mon ...... oma Treated With Chemotherapy.

@nl

prefLabel

Pretreatment Lymphocyte to Mon ...... oma Treated With Chemotherapy.

@en

Pretreatment Lymphocyte to Mon ...... oma Treated With Chemotherapy.

@nl

P1476

Pretreatment Lymphocyte to Mon ...... oma Treated With Chemotherapy.

@en

P2093

Kiyoshi Komuta

http://www.w3.org/2001/XMLSchema#string

Seigo Minami

http://www.w3.org/2001/XMLSchema#string

Shouichi Ihara

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and cancer

Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysis

Chemotherapy near the end of life: a retrospective single-centre analysis of patients' charts.

The impact of de novo liver metastasis on clinical outcome in patients with advanced non-small-cell lung cancer.

The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study

Prognostic significance of systemic inflammation-based lymphocyte- monocyte ratio in patients with lung cancer: based on a large cohort study.

Glasgow prognostic score in patients receiving chemotherapy for non-small-cell lung cancer in stages IIIb and IV.

The revised TNM staging system for lung cancer.

Lung cancer incidence trends by gender, race and histology in the United States, 1973-2010

The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.

P304

657-664

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14740/JOCMR3490W

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29977424

http://www.w3.org/2001/XMLSchema#string

P932

6031246

http://www.w3.org/2001/XMLSchema#string